Ginkgo Biloba Leaf Extract 50:1 (24% Flavonoid glycosides, 6% Terpene lactones)
Mechanism of Action +
### Phytochemical Composition and Standardization The clinical efficacy of Ginkgo biloba is highly dependent on its specific phytochemical standardization. The industry and clinical standard, often referred to by the trademarked designation EGb-761, is a 50:1 concentrated extract. This means 50 parts of raw dried leaves yield 1 part of finished extract (e.g., 300mg of extract is derived from 15g of dry leaves). The extract is strictly standardized to contain 24% flavone glycosides (primarily quercetin, kaempferol, and isorhamnetin derivatives) and 6% terpene lactones (comprising ginkgolides A, B, C, J, M, and bilobalide). Furthermore, toxic ginkgolic acids must be removed to a concentration of less than 5-10 parts per million (ppm).
### Terpene Lactones: PAF Antagonism and Neuroprotection The terpene trilactones (TTLs) are unique to the Ginkgo species and are responsible for its most profound pharmacological effects. Ginkgolide B is a highly specific and potent competitive antagonist of the platelet-activating factor (PAF) receptor. PAF is a proinflammatory phospholipid mediator that induces platelet aggregation, neutrophil degranulation, and the production of reactive oxygen species (ROS). By blocking the PAF receptor, ginkgolide B reduces blood viscosity, inhibits microthrombus formation, and enhances cerebral and peripheral microcirculation. This rheological improvement is a primary mechanism behind Ginkgo's use in cognitive decline and peripheral vascular conditions.
Bilobalide, another major terpene lactone, exhibits distinct neuroprotective properties. It does not antagonize PAF but instead acts at the mitochondrial level. Bilobalide preserves mitochondrial ATP synthesis, stabilizes the mitochondrial membrane potential, and inhibits hypoxia-induced downregulation of mitochondrial DNA. It also modulates GABAergic transmission, acting as a negative allosteric modulator at GABA_A receptors, which may contribute to its neurotrophic and anticonvulsant-like properties in specific models, though high doses can lower the seizure threshold.
### Flavone Glycosides: Antioxidant and Free Radical Scavenging The 24% flavone glycoside fraction consists mainly of the aglycones quercetin, kaempferol, and isorhamnetin linked to various sugar moieties. These flavonoids are potent scavengers of superoxide anions, hydroxyl radicals, and peroxyl radicals. In the central nervous system, where lipid-rich neuronal membranes are highly susceptible to lipid peroxidation, these flavonoids protect structural integrity. They also upregulate endogenous antioxidant enzymes, including superoxide dismutase (SOD) and catalase, and modulate intracellular signaling pathways such as MAPK and PI3K/Akt, promoting neuronal survival and neurogenesis.
### Pharmacokinetics and Bioavailability The pharmacokinetic profile of Ginkgo's active constituents is remarkably favorable compared to many other botanical extracts. The terpene lactones exhibit high oral bioavailability: Ginkgolide A is approximately 80% bioavailable, Ginkgolide B is 88%, and Bilobalide is 79%. They reach peak plasma concentrations (Tmax) within 1 to 2 hours post-ingestion. The elimination half-lives range from 3 to 4 hours for bilobalide to roughly 10 hours for ginkgolide B. The flavone glycosides undergo extensive metabolism by the gut microbiome before absorption, primarily circulating as glucuronidated or sulfated conjugates of their respective aglycones.
What is Ginkgo biloba supplement used for? +
What are the bad side effects of ginkgo biloba? +
What does 50:1 extract mean? +
What are the benefits of terpene lactones? +
What medications should not be taken with ginkgo biloba? +
What supplements should not be taken with ginkgo biloba? +
Is ginkgo biloba have side effects? +
Who should not have ginkgo biloba? +
Can ginkgo biloba cause heart problems? +
What is EGb-761? +
How long does it take for Ginkgo biloba to work? +
Does Ginkgo biloba help with tinnitus? +
Why is Ginkgo biloba often faked or adulterated? +
What are ginkgolic acids? +
Should I take Ginkgo biloba with food? +
Everything About Ginkgo Biloba Leaf Extract 50:1 (24% Flavonoid glycosides, 6% Terpene lactones) Article
## The Definitive Guide to Ginkgo Biloba Leaf Extract 50:1
Ginkgo biloba, often referred to as the Maidenhair tree or the "fossil tree," is one of the oldest living tree species on Earth, with a botanical lineage stretching back over 200 million years. While its leaves have been utilized in traditional Chinese medicine for centuries, modern clinical science focuses almost exclusively on highly concentrated, standardized extracts.
Today, Ginkgo biloba is the most commonly used herbal supplement for brain health worldwide. However, not all Ginkgo is created equal. The clinical efficacy of this ancient botanical hinges entirely on a specific extraction ratio and phytochemical standardization: the 50:1 extract containing 24% flavonoid glycosides and 6% terpene lactones.
### What Does "50:1 (24/6)" Actually Mean?
When you see "Ginkgo Biloba Leaf Extract 50:1" on a supplement panel, it denotes the concentration ratio. It takes 50 pounds of raw, dried Ginkgo leaves to produce just 1 pound of the finished extract. For context, a standard clinical dose of 300mg of this extract is the bioactive equivalent of consuming 15 grams of dried leaves.
The "24/6" designation refers to the strict phytochemical standardization required to match the extracts used in clinical trials (most notably the trademarked EGb-761): * **24% Flavonoid Glycosides:** These are the primary antioxidants in Ginkgo. They consist mainly of quercetin, kaempferol, and isorhamnetin. They protect brain cells from free radical damage and oxidative stress. * **6% Terpene Lactones:** These are the unique, highly bioactive compounds found *only* in the Ginkgo tree. They include ginkgolides (A, B, C, J, M) and bilobalide. These compounds are responsible for Ginkgo's ability to improve blood flow and protect mitochondria.
### Mechanisms of Action: How Ginkgo Upgrades the Brain
The cognitive and circulatory benefits of Ginkgo biloba are driven by a multi-targeted pharmacological approach.
#### 1. Platelet-Activating Factor (PAF) Antagonism Ginkgolide B, one of the primary terpene lactones, is a potent competitive antagonist of the PAF receptor. PAF is a molecule that causes blood platelets to stick together (aggregate) and triggers inflammatory responses. By blocking PAF, Ginkgo biloba reduces blood viscosity (making the blood "thinner" and less sticky). This dramatically improves microcirculation—the flow of blood through the tiniest capillaries in the brain, eyes, and extremities. Better blood flow means enhanced delivery of oxygen and glucose to demanding neural tissues.
#### 2. Mitochondrial Protection via Bilobalide While ginkgolides handle blood flow, bilobalide protects the brain's power plants. Research indicates that bilobalide preserves mitochondrial ATP (energy) synthesis, especially under conditions of stress, hypoxia (low oxygen), or ischemia (restricted blood supply). It stabilizes the mitochondrial membrane, ensuring that neurons have the energy required to fire efficiently and maintain synaptic plasticity.
#### 3. Broad-Spectrum Antioxidant Defense The brain is highly susceptible to oxidative stress due to its massive oxygen consumption and lipid-rich structure. The 24% flavone glycoside fraction in standardized Ginkgo acts as a robust free radical scavenger. Compounds like quercetin and kaempferol neutralize superoxide and hydroxyl radicals before they can damage neuronal cell membranes, thereby slowing age-related cognitive decline.
### Clinical Evidence and Efficacy
The Examine.com database tracks 72 trials and 5 meta-analyses involving over 30,900 participants regarding Ginkgo biloba. The evidence presents a nuanced picture:
* **Cognitive Decline in Aging:** Ginkgo shows its strongest cognitive benefits in older populations experiencing mild cognitive impairment or age-related cognitive decline. In these demographics, it can improve memory recall, executive function, and daily living activities. However, Examine notes that as a general "smart drug" for healthy, young individuals, its effects are "not very reliable or generalizable." * **Acute Mountain Sickness:** Ginkgo holds a Grade B evidence rating for alleviating symptoms of acute mountain sickness. Its ability to improve oxygen utilization and cerebral blood flow makes it a valuable prophylactic for high-altitude climbers. * **Peripheral Circulation:** By improving rheology (blood flow dynamics), Ginkgo is frequently used to treat conditions related to poor peripheral circulation, such as intermittent claudication (leg pain caused by restricted blood flow).
### The Dark Side of the Market: Adulteration and Spiking
Because authentic 50:1 Ginkgo extract is expensive to produce, it is one of the most frequently adulterated botanical ingredients on the market.
A landmark 2011 study published in the *Journal of Functional Foods* by Chandra et al., titled "Qualitative categorization of supplement grade Ginkgo biloba leaf extracts for authenticity," exposed widespread industry fraud. Because the 6% terpene lactones are unique to Ginkgo and expensive to extract, many suppliers focus only on hitting the 24% flavone glycoside number.
To fake this, unethical manufacturers "spike" cheap, low-grade Ginkgo powder with inexpensive flavonoids sourced from other plants (like rutin from buckwheat or sophoricoside from Japanese pagoda tree). The study established that authentic Ginkgo must possess a specific Quercetin/Kaempferol/Isorhamnetin (Q/K/I) peak area ratio. If a supplement brand does not perform advanced HPLC testing to verify these ratios, there is a high probability the Ginkgo is adulterated.
### Safety, Toxicity, and Ginkgolic Acids
While standardized Ginkgo is generally safe, raw Ginkgo leaves contain high levels of ginkgolic acids, which are highly allergenic, cytotoxic, and potentially mutagenic. High-quality 50:1 extracts undergo a specific purification step to remove these toxins, ensuring the final product contains less than 5 parts per million (ppm) of ginkgolic acids.
Furthermore, because Ginkgo is such an effective PAF antagonist, it acts as a mild blood thinner. It should never be combined with prescription anticoagulants (like Warfarin) or high doses of NSAIDs (like Aspirin) without strict medical supervision, as this can lead to severe bleeding events.
### Dosing Protocols
Clinical trials consistently utilize doses ranging from **120mg to 240mg per day** of the standardized 50:1 extract. This is typically split into two or three doses throughout the day (e.g., 60mg to 120mg taken twice daily) to maintain stable blood levels of the active terpenes.
Beware of "fairy-dusted" supplements. Our catalog data reveals multi-ingredient formulas containing as little as 25mg of Ginkgo biloba. At this dose, the ingredient is entirely subclinical and serves only as a label claim.